首年营收破百万美元!BIOTROP携生物制剂强势进军美国农业市场
世界农化网中文网报道: 美国农民已开始了解并使用BIOTROP的现代生物技术。BIOTROP是一家全球生物投入品公司,隶属于Biofirst集团,该集团年收入达5.8亿美元,处于全球领先地位。在美国销售的第一年,BIOTROP的营业额达到了130万美元。BIOTROP向美国农民提供生物杀菌剂、生物杀线虫剂和土壤调理剂,产品主要面向大豆、玉米、小麦、棉花和花生。
长江大学农药团队在新型杀线虫化合物研究中取得进展
世界农化网中文网报道:长江大学农学院农药学团队徐志红副教授课题组连续在农药学领域权威期刊《Journal of Agricultural and Food Chemistry》和《Pest Management Science》上发表研究论文,报道了该课题组进行新型杀线虫剂创制的阶段性成果,为解决植物线虫病防治的难题提供了坚实的理论和技术基础。
预计今年夏季草地贪夜蛾在西南及华南地区中等程度发生
世界农化网中文网报道:全国农技推广中心:受境内外虫源基数下降影响,今年春季草地贪夜蛾在西南华南地区总体轻发生,根据当前各地虫量、夏季天气条件和玉米种植因素综合分析,预计夏季草地贪夜蛾总体偏轻至中等发生,全国发生面积3000万亩次。
法国种业巨头Limagrain获3亿欧元贷款,押注植物遗传学
世界农化网中文网报道:近日,欧洲投资银行(EIB)宣布向法国种业巨头、全球第四大种子企业 Limagrain 提供3亿欧元长期贷款,用于加速植物遗传学领域研发。这被欧洲投资银行称为其在欧洲农业领域迄今规模最大的融资项目之一。此次融资将支持利马格兰旗下 Vilmorin & Cie 主导开展的育种创新项目,重点围绕提高作物产量、抗病虫害能力、耐旱性、区域适应性以及养分利用效率,同时进一步改善作物的营养品质和环境表现。
Defective HIV RNA Linked to Persistent Viremia During Long-Term ART
Credit: MedicalRF.com/Getty ImagesAntiretroviral therapy (ART) has enabled most people living with HIV to live long and healthy lives. However, a small portion of people experience detectable traces of the virus, known as nonsuppressible viremia (NSV), despite strict adherence to long-term treatment regimens and the absence of symptoms. The results of a study headed by researchers at Johns Hopkins University School of Medicine now suggest that most cases of NSV are explained by defective and noninfectious copies of the virus.
AI Reimagines Caffeine as a Molecular Off‑Switch for Engineered Cells
A cup of coffee can mean many things: a daily part of our routine, a moment of calm, a midday boost. But zoom in past the steam, past the roasted aromatics, down to the caffeine molecule itself, and a different story emerges. At the Texas A&M Health Institute of Biosciences and Technology, researchers have turned this everyday stimulant into something far more unexpected: a molecular “pause button” for engineered cells.
Men’s fragrance brand Axe partners with FIFA to deliver Gen Z-inspired scents
Axe — known as Lynx in the UK — has partnered with the FIFA World Cup 2026 to launch three limited-edition fragrances from its Fine Fragrance collection. Young men today are redefining the fragrance sector, moving beyond fresh scents toward sweeter, creamier notes and luxury-inspired formats.
Investment Climate Podcast: Lauren Abda of Branch Venture Group Shares How to Get Funded in 2026
In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2026 and uncovers the investment playbooks of successful Climate Tech CEOs and Leading VCs.
Ingredion seals Tate & Lyle takeover, uniting specialty suppliers with personal care reach
Ingredion has announced a recommended all-cash offer to acquire Tate & Lyle, valuing the target’s share capital at roughly £2.7 billion (US$3.6 billion) and implying an enterprise value of approximately £3.7 billion (US$5 billion). Tate & Lyle’s board has unanimously recommended the offer to shareholders.
Ingredion Strikes £3.7 Billion ($5 Billion) Deal to Acquire UK Ingredient Giant Tate & Lyle
US ingredient solutions company Ingredion has announced a recommended all-cash offer to acquire London-listed Tate & Lyle PLC in a deal that values the business at approximately £3.7 billion ($5 billion).
